开发一种增长因子生物可用性增强全移植 (GFBA) 用于骨再生
Marie-Soleil R Smith1, Sowmya Shivanna1, Yakup Kohen1,2,3
1Red Rock Regeneration Inc, Toronto, ON, Canada.
Cell and tissue banking
|January 22, 2026
概括
一种新的加工方法,Natural Matrix Protein (NMP),通过增加骨形态遗传蛋白 (BMP) 的生物可用性来增强骨异构蛋白的生物活性,从而改善了临床前研究中的骨再生.
科学领域:
- 生物材料科学 生物材料科学
- 整形外科手术 整形外科手术
- 再生医学是一种再生医学.
背景情况:
- 骨形态遗传蛋白 (BMP) 对于骨质诱导和骨再生至关重要.
- 人类非矿物化骨基质 (DBM) 是一种常见的骨移植替代品,但由于加工限制,其骨质诱导潜力有限.
- 在全移植中提高本源BMPs的生物可用性是提高骨再生效率的关键.
研究的目的:
- 引入一种新的加工方法,即天然矩阵蛋白 (NMP),旨在通过增加本源BMP生物可用性来增强全移植生物活性.
- 从NMP和DBM中量化BMP-7的释放.
- 在体外和体内评估NMP的骨诱导潜力.
主要方法:
- 从NMP和DBM (牛和人类) 中量化了BMP-7的释放,使用酸性和生理学提取物.
- 持续释放的BMP-7和总蛋白质被评估超过12周在模拟的体液.
- 在实验室中,使用C2C12细胞 (性酸酶活性) 评估了骨诱导潜力.
- 活体内骨质诱导性在无血性大鼠中进行了评估,将人类NMP与人类DBM进行比较,并使用组织学和微CT进行输入骨移植.
主要成果:
- 与DBM相比,NMP在牛和人类骨中显著增加了BMP-7水平.
- 在NMP中,BMP-7和总蛋白质持续释放长达12周.
- 在实验室中,NMP诱导性酸酶活性增加了十倍以上.
- 人类NMP在体内表现出增强的骨质诱导性,与DBM和输入骨移植相比,骨矿化显著增加,骨体积分数更高.
结论:
- 新的NMP过程有效地增加了BMP-7的生物可用性,并增强了全移植骨诱导性.
- NMP植入物促进了BMP和总蛋白质的持续释放.
- 对于改善骨再生应用,NMP显示出显著的潜力.
相关概念视频
01:22Bioavailability: Influencing Factors
352
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
352
01:16Bioavailability Enhancement: Drug Solubility Enhancement
229
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
229
01:27Bioavailability Enhancement: Drug Permeability Enhancement
194
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
194
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
198
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
198
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
203
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
203
01:23Factors Influencing Bioavailability: First-Pass Elimination
8.0K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
8.0K